WHO says India has much to do on toxic cough syrup despite some progress


Tests showed that Coldrif cough medicine contained the toxin diethylene glycol in quantities nearly 500 times the permissible limit. - Photo: Reuters

LONDON: India has more work to do in halting sales of toxic cough syrup, despite some progress, a World Health Organisation (WHO) official told Reuters, after at least 24 children died following consumption of a domestically made medicine.

The children died after taking Coldrif cough medicine made by Sresan Pharma, which tests showed contained the toxin diethylene glycol in quantities nearly 500 times the permissible limit.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Aseanplus News

Galloping into the new year: Singapore Mint Lunar Fair opens at Chinatown Point Atrium
Asean News Headlines at 10pm on Thursday (Jan 1, 2026)
Female nail technician found dead in Mito, Japan with apparent stab wound to neck
Philippines raises Mayon Volcano alert level amid signs of increased unrest
Selangor PAS Youth supports Sanusi to lead Perikatan
BTS to make full comeback with new album in March after nearly four years
Brunei Ruler reaffirms commitment to economic resilience, national well-being
Negri Bersatu backs Abdul Hadi as next Perikatan chief
Thai fortune-teller predicts client’s bad luck, then gets arrested over stealing her phone
Dense fog disrupts flights across northern and eastern India, including New Delhi

Others Also Read